Welcome to GTx.

GTx is a biopharmaceutical company dedicated to the discovery, development, and commercialization of small molecules that selectively target hormone pathways to treat cancer, osteoporosis and bone loss, muscle wasting, and other serious medical conditions.

To learn more, we invite you to explore our site.

 

GTx, Inc. Announces Second Quarter 2008 Financial Results Conference Call and Webcast

GTx, Inc. at Goldman Sachs Healthcare Conference

GTx Announces Webcast of Corporate Presentation at Goldman Sachs 29th Annual Global Healthcare Conference
GTx Announces Phase III PIN Clinical Trial Will Continue As Planned